# | Drug | Count |
---|---|---|
0 | TREPROSTINIL | 77 |
1 | SILDENAFIL CITRATE | 66 |
2 | AMBRISENTAN | 65 |
3 | MACITENTAN | 57 |
4 | TADALAFIL | 55 |
5 | BOSENTAN | 44 |
6 | RIOCIGUAT | 43 |
7 | SILDENAFIL | 40 |
8 | SELEXIPAG | 37 |
9 | SILDINAFIL | 28 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | SELEXIPAG | 37 | 0.0029 |
1 | RIOCIGUAT | 43 | 0.0026 |
2 | EPOPROSTENOL | 23 | 0.0023 |
3 | ILOPROST | 15 | 0.0017 |
4 | ECONAZOLE NITRATE | 1 | 0.0017 |
5 | EPOPROSTENOL SODIUM | 10 | 0.0017 |
6 | MACITENTAN | 57 | 0.0016 |
7 | SILDINAFIL | 28 | 0.0013 |
8 | TREPROSTINIL | 77 | 0.0011 |
9 | BOSENTAN | 44 | 0.0010 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Prostacyclin Receptor Agonist [EPC] | 37 | 0.0029 |
1 | Soluble Guanylate Cyclase Stimulator [EPC] | 43 | 0.0026 |
2 | Prostacycline [EPC] | 15 | 0.0017 |
3 | Prostacycline Vasodilator [EPC] | 95 | 0.0012 |
4 | Phosphodiesterase 5 Inhibitor [EPC] | 83 | 0.0010 |
5 | Endothelin Receptor Antagonist [EPC] | 125 | 0.0009 |
6 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 3 | 0.0007 |
7 | Paramagnetic Contrast Agent [EPC] | 2 | 0.0005 |
8 | Pyridone [EPC] | 8 | 0.0004 |
9 | Aldosterone Antagonist [EPC] | 18 | 0.0002 |